Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125559601 | 12555960 | 1 | I | 20160526 | 0 | 20160713 | 20160713 | DIR | 46.00 | YR | F | N | 148.00000 | LBS | 20160712 | Y | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125559601 | 12555960 | 1 | PS | ALEMTUZUMAB GENZYME | ALEMTUZUMAB | 1 | Intravenous (not otherwise specified) | D | D | 14-01372 | 201510 | 0 | 12 | MG | QD | ||||
| 125559601 | 12555960 | 2 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | D | D | J00855 | 201806 | 0 | 1 | MG | QD | ||||
| 125559601 | 12555960 | 4 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 14 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 16 | C | PROVIGIL | MODAFINIL | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 18 | C | TIZANIDINE. | TIZANIDINE | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 20 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125559601 | 12555960 | 22 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125559601 | 12555960 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125559601 | 12555960 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125559601 | 12555960 | Chest pain | |
| 125559601 | 12555960 | Cough | |
| 125559601 | 12555960 | Decreased appetite | |
| 125559601 | 12555960 | Dyspnoea | |
| 125559601 | 12555960 | Histoplasmosis disseminated | |
| 125559601 | 12555960 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125559601 | 12555960 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125559601 | 12555960 | 1 | 20150119 | 20150121 | 0 | |
| 125559601 | 12555960 | 2 | 20150119 | 20150121 | 0 |